Based on the provided data, diuretic medicine sales in Australia from 2024 to 2028 are forecasted to remain constant at 1.9 US Dollars Per Capita. In 2023, the value stood at 1.9 US Dollars Per Capita as well, indicating no year-on-year variation or change in sales over this forecast period. Over the last two years, the sales have shown no change, leading to a Compound Annual Growth Rate (CAGR) of 0% over the last five years. This consistency highlights a stable demand for diuretics in the Australian market.

Future trends to watch for:

Potential impact of new pharmaceutical alternatives or enhancements in diuretic therapies.
Changes in healthcare policies or insurance coverage affecting diuretic prescriptions.
Evolving demographic and health trends, such as aging population or lifestyle-related conditions.